Literature DB >> 9401055

CD34+ peripheral blood progenitor cell and monocyte derived dendritic cells: a comparative analysis.

B Herbst1, G Köhler, A Mackensen, H Veelken, R Mertelsmann, A Lindemann.   

Abstract

Dendritic cells (DC) have been generated in vitro from either CD34+ haemopoietic progenitor cells (HPC) or peripheral blood monocytes (Mo) in the presence of specific cytokine combinations, including granulocyte-macrophage colony-stimulating factor (GM-CSF). Since differences between DC from either source may be important for the clinical use of these antigen-presenting cells (APC), a comparative analysis was performed. HPC were expanded in the presence of interleukin (IL)-3, IL-6 and stem cell factor (SCF) (days 1-7) and subsequently induced by IL-4+ GM-CSF (days 8-26) to differentiate to Langerhans-type cells (pLC). The latter cytokines were similarly used to generate Mo-derived LC (mLC). Maturation of both cell types, pLC and mLC, to interdigitating DC-type cells (iDC) was induced by tumour necrosis factor-alpha (TNF-alpha) or lipopolysaccharide (LPS). Analysis of mLC/pLC and miDC/piDC with respect to morphology, phenotype, antigen uptake and presentation revealed a high similarity of DC from either source. The majority of mLC, however, exhibited a more mature differentiation stage, compared to pLC, evidenced from lower numbers of multilaminar MHC class II compartments and less efficient APC function for extracellular protein antigens. Although macropinocytosis was performed by LC, neither LC nor iDC from either source were able to take up > or = 0.5 microm latex beads. However, phagocytosis of 0.5 microm and 1 microm beads was performed by Mo that could subsequently be induced to become iDC, thus providing the unique opportunity to present phagocytosed material in DC-type fashion. Mo may be the preferential source for clinical use of iDC-type cells since preparation and culture are easier to perform and are less costly while APC function is similar to HPC-derived iDC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9401055     DOI: 10.1046/j.1365-2141.1997.4283238.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

1.  Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells.

Authors:  P E Mangeot; D Nègre; B Dubois; A J Winter; P Leissner; M Mehtali; D Kaiserlian; F L Cosset; J L Darlix
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 2.  Dendritic cells in the host response to implanted materials.

Authors:  Benjamin G Keselowsky; Jamal S Lewis
Journal:  Semin Immunol       Date:  2017-05-07       Impact factor: 11.130

3.  Efficient ex vivo generation of human dendritic cells from mobilized CD34+ peripheral blood progenitors.

Authors:  K Ohishi; N Katayama; H Mitani; H Araki; M Masuya; H Suzuki; N Hoshino; H Miyashita; K Nishii; S Kageyama; N Minami; H Shiku
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

4.  CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells.

Authors:  G Hartmann; G J Weiner; A M Krieg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

Review 5.  Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma.

Authors:  R Hájek; A W Butch
Journal:  Med Oncol       Date:  2000-02       Impact factor: 3.064

6.  A human coronavirus responsible for the common cold massively kills dendritic cells but not monocytes.

Authors:  Mariana Mesel-Lemoine; Jean Millet; Pierre-Olivier Vidalain; Helen Law; Astrid Vabret; Valérie Lorin; Nicolas Escriou; Matthew L Albert; Béatrice Nal; Frédéric Tangy
Journal:  J Virol       Date:  2012-05-02       Impact factor: 5.103

7.  HIV-1 infection of placental cord blood monocyte-derived dendritic cells.

Authors:  R M Folcik; J D Merrill; Y Li; C J Guo; S D Douglas; S E Starr; W Z Ho
Journal:  J Hematother Stem Cell Res       Date:  2001-10

8.  Monocyte-derived dendritic cells from horses differ from dendritic cells of humans and mice.

Authors:  Susanne Mauel; Falko Steinbach; Hanns Ludwig
Journal:  Immunology       Date:  2006-04       Impact factor: 7.397

9.  Analysis of a chronic myelogenous leukemia patient vaccinated with leukemic dendritic cells following autologous peripheral blood stem cell transplantation.

Authors:  S Fujii; K Shimizu; K Fujimoto; T Kiyokawa; T Shimomura; M Kinoshita; F Kawano
Journal:  Jpn J Cancer Res       Date:  1999-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.